Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0315534 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Tengda Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy, West China Hospital…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Vesicular Transport Proteins, Microfilament Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Project, Science and Technology Project of Sichuan Province.
Abstract (Originalsprache)
Introduction
Hepatocellular carcinoma is one of the leading causes of cancer-related mortality worldwide. The actin-binding protein Girdin is overexpressed in various tumors, promoting tumorigenesis and progression. However, the exact mechanisms by which Girdin regulates liver cancer remain poorly understood.
Methods
This study comprehensively analyzed the expression level of Girdin in liver cancer and adjacent tissue, along with the correlation between Girdin expression and the clinical characteristics and prognosis of liver cancer. The analysis integrated data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and Clinical Proteomic Tumor Analysis Consortium (CPTAC) database. Subsequently, Girdin expression was knocked down to elucidate its role in the progression of liver cancer. Transcriptome sequencing was employed to investigate the mechanistic underpinnings of Girdin’s regulatory impact on liver cancer. Additionally, the Comparative Toxicogenomics Database (CTD) was utilized to identify potential drugs or molecules for liver cancer treatment.
Results
The findings revealed elevated Girdin expression in liver cancer tissues, and heightened Girdin expression correlating with adverse clinical features and prognosis. Silencing of Girdin markedly impeded the proliferation and migration of hepatocellular carcinoma cells. Moreover, transcriptome sequencing demonstrated that silencing Girdin led to differential expression of 176 genes and inhibition of the PI3K/Akt signaling pathway, as well as its upstream pathways—Cytokine-cytokine receptor interaction and Chemokine signaling pathway. Ultimately, we propose that Imatinib Mesylate, Orantinib, Resveratrol, Sorafenib, and Curcumin may interact with Girdin, potentially contributing to the treatment of liver cancer.
Conclusion
This study reveals the association between Girdin and hepatocellular carcinoma, providing novel clues for future research and treatment of hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
- Cytology and Molecular Platform, Core Facilities of West China Hospital, Chengdu, China.
- NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, Chi…
- Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Tengda Huang, Fang He
Förderung
- Key Research and Development Project, Science and Technology Project of Sichuan Province
Zitieren
APA
Huang, T., Chen, H., Pan, H., Wu, T., Ren, X., Qin, L., Yuan, K., & He, F. (2024). Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0315534
Vancouver
Huang T, Chen H, Pan H, Wu T, Ren X, Qin L, et al. Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma. PLOS ONE. 2024. doi:10.1371/journal.pone.0315534
BibTeX
@article{Huang2024,
author = {Huang, Tengda and Chen, Hongying and Pan, Hongyuan and Wu, Tian and Ren, Xiangyi and Qin, Liwen and Yuan, Kefei and He, Fang},
title = {Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0315534}
}
EUVIMED